Brinzolamide - Glaucoma / ocular hypertension
You are here : Home > Formulary Search > Brinzolamide - Glaucoma / ocular hypertension
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Eye drops
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Brinzolamide
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
Intra-ocular pressure
Brand Names Include :
Azopt
Important Information :
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Brinzolamide is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.
- Acetazolamide
- Apraclonidine
- Betaxolol
- Bimatoprost
- Bimatoprost with timolol
- Brimonidine tartrate
- Brimonidine with timolol
- Brinzolamide with brimonidine
- Brinzolamide with timolol
- Dorzolamide
- Dorzolamide with timolol
- Latanoprost
- Latanoprost with netarsudil
- Latanoprost with timolol
- Levobunolol hydrochloride
- Pilocarpine hydrochloride
- Tafluprost
- Timolol
- Travoprost
- Travoprost with timolol
Committee Recommendations (2)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.
Note; the branded product (Azopt) was considered as BLACK at the PCN in May 2017.